Celldex Therapeutics Inc

CLDX NASDAQ Santé & Biotech États-Unis US15117B2025
29.60 $
3.64 %

Entreprise biopharmaceutique concentrée sur le développement et la commercialisation de thérapies ciblées pour des besoins médicaux non satisfaits, notamment en oncologie.

Performance & Momentum

6 Months 0.57 %
1 Year 51.35 %
3 Years 12.47 %
5 Years 6.66 %

Similar stocks to Celldex Therapeutics Inc

Anantys Community

Be the first to share your analysis on Celldex Therapeutics Inc.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases